These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36441595)

  • 1. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
    Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
    J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib.
    Chen T; Song C; Liang G; Xu X; Wang C; Zhang Z; Tang M
    Dis Markers; 2022; 2022():5879137. PubMed ID: 35356064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
    Deng M; Ma X; Liang X; Zhu C; Wang M
    Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Neutrophil-Lymphocyte Ratio (NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR)-Binding Fibrinogen-Albumin Ratio (FAR) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma.
    Zhao X; Zhou Y; Liu B; Shen Y; Qian J; Zhang X; Zhao H
    Med Sci Monit; 2023 Mar; 29():e939442. PubMed ID: 36992543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-D and PLR, NLR combined forecasting first-line treatment: The short-term curative effect and prognosis of patients with SCLC.
    Hu H; Chen WJ; Sun C; Xie JP
    Medicine (Baltimore); 2023 Nov; 102(45):e34877. PubMed ID: 37960828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma.
    Yapar A; Tokgöz MA; Yapar D; Atalay İB; Ulucaköy C; Güngör BŞ
    Jt Dis Relat Surg; 2021; 32(2):489-496. PubMed ID: 34145828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
    Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
    Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
    Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study.
    Wang Y; Zhang H; Yang Y; Zhang T; Ma X
    Front Oncol; 2019; 9():995. PubMed ID: 31649874
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer.
    Chen Y; Wang W; Zhang X; Yu X; Xi K; Wen Y; Wang G; Feng X; Zhang L
    Cancer Manag Res; 2018; 10():5411-5422. PubMed ID: 30519089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab.
    Qi WX; Xiang Y; Zhao S; Chen J
    Cancer Immunol Immunother; 2021 Nov; 70(11):3199-3206. PubMed ID: 33796915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
    Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
    BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase.
    Xiong Q; Huang Z; Xin L; Qin B; Zhao X; Zhang J; Shi W; Yang B; Zhang G; Hu Y
    Cancer Immunol Immunother; 2021 Mar; 70(3):713-720. PubMed ID: 32910245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoglobin, albumin, lymphocyte, and platelet score and neutrophil-to-lymphocyte ratio are novel significant prognostic factors for patients with small-cell lung cancer undergoing chemotherapy.
    Yang N; Han X; Yu J; Shu W; Qiu F; Han J
    J Cancer Res Ther; 2020 Sep; 16(5):1134-1139. PubMed ID: 33004760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors.
    Liu N; Mao J; Tao P; Chi H; Jia W; Dong C
    Medicine (Baltimore); 2022 Jan; 101(3):e28617. PubMed ID: 35060536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of preoperative neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and lymphocyte- to-monocyte ratio for patients with muscle- invasive bladder cancer undergoing radical cystectomy.
    Lei Y; Jiao D; Yao Z; Wang L; Zhao Z
    Arch Esp Urol; 2022 Apr; 75(3):287-294. PubMed ID: 35435163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
    Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
    Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.
    Yang L; Fu M; Yu L; Wang H; Chen X; Sun H
    Front Endocrinol (Lausanne); 2024; 15():1293842. PubMed ID: 38370351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.